Editorial: Targeting TNF/TNFR signaling pathways.
作者信息
Pan Liqiang, Chou James J, Fu Tianmin
机构信息
Zhejiang University, Hangzhou, China.
Harvard Medical School, Boston, MA, United States.
出版信息
Front Pharmacol. 2023 Jan 4;13:1120954. doi: 10.3389/fphar.2022.1120954. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Targeting TNF/TNFR signaling pathways.社论：靶向肿瘤坏死因子/肿瘤坏死因子受体信号通路
Front Pharmacol. 2023 Jan 4;13:1120954. doi: 10.3389/fphar.2022.1120954. eCollection 2022.
2
Anti-Fn14 Antibody-Conjugated Nanoparticles Display Membrane TWEAK-Like Agonism.抗Fn14抗体偶联纳米颗粒表现出类似膜TWEAK的激动作用。
Pharmaceutics. 2021 Jul 13;13(7):1072. doi: 10.3390/pharmaceutics13071072.
3
Tumor Necrosis Factor Receptor Mediates Fibroblast Growth Factor-Inducible 14 Signaling.肿瘤坏死因子受体介导成纤维细胞生长因子诱导蛋白14信号传导。
Cell Physiol Biochem. 2017;43(2):579-588. doi: 10.1159/000480530. Epub 2017 Sep 21.
4
Antitumor activities of agonistic anti-TNFR antibodies require differential FcγRIIB coengagement in vivo.激动型抗 TNF 受体抗体的抗肿瘤活性需要体内差异化的 FcγRIIB 共结合。
Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):19501-6. doi: 10.1073/pnas.1319502110. Epub 2013 Nov 11.
5
Targeting fibroblast growth factor (FGF)-inducible 14 (Fn14) for tumor therapy.靶向成纤维细胞生长因子（FGF）诱导的14（Fn14）用于肿瘤治疗。
Front Pharmacol. 2022 Oct 21;13:935086. doi: 10.3389/fphar.2022.935086. eCollection 2022.
6
Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activity.成纤维细胞生长因子诱导型（Fn14）特异性抗体同时表现出信号通路特异性激动和拮抗活性。
J Biol Chem. 2013 May 10;288(19):13455-66. doi: 10.1074/jbc.M112.435917. Epub 2013 Mar 26.
7
Tumor Necrosis Factor (TNF) Receptor Expression Determines Keratinocyte Fate upon Stimulation with TNF-Like Weak Inducer of Apoptosis.肿瘤坏死因子（TNF）受体表达决定角质形成细胞在 TNF 样凋亡弱诱导剂刺激下的命运。
Mediators Inflamm. 2019 Dec 5;2019:2945083. doi: 10.1155/2019/2945083. eCollection 2019.
8
Novel Immunoliposome Technology for Enhancing the Activity of the Agonistic Antibody against the Tumor Necrosis Factor Receptor Superfamily.新型免疫脂质体技术增强抗肿瘤坏死因子受体超家族激动性抗体的活性
Mol Pharm. 2018 Sep 4;15(9):3729-3740. doi: 10.1021/acs.molpharmaceut.7b01167. Epub 2018 Apr 27.
9
Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death.成纤维细胞生长因子诱导蛋白14介导肿瘤坏死因子样弱凋亡诱导因子诱导的细胞死亡的多种途径。
J Immunol. 2003 Jan 1;170(1):341-8. doi: 10.4049/jimmunol.170.1.341.
10
Fc Engineering Approaches to Enhance the Agonism and Effector Functions of an Anti-OX40 Antibody.增强抗OX40抗体激动活性和效应功能的Fc工程方法。
J Biol Chem. 2016 Dec 30;291(53):27134-27146. doi: 10.1074/jbc.M116.757773. Epub 2016 Nov 17.
引用本文的文献
1
Regulation of anti-tumour effects of Paris polyphylla saponins via ROS: molecular mechanisms and therapeutic potentials.重楼皂苷通过活性氧调节抗肿瘤作用：分子机制与治疗潜力
Front Pharmacol. 2025 Jul 2;16:1611911. doi: 10.3389/fphar.2025.1611911. eCollection 2025.
2
Network Pharmacology and Experimental Validation Reveal Ganodermanontriol Modulates Pneumonia via TNF/NF-κB/MAPKs Signaling Pathway.网络药理学与实验验证揭示灵芝三萜通过TNF/NF-κB/MAPKs信号通路调节肺炎
Food Sci Nutr. 2025 Mar 25;13(4):e70123. doi: 10.1002/fsn3.70123. eCollection 2025 Apr.
3
Immunogenic cell death-related cancer-associated fibroblast clusters and prognostic risk model in cervical cancer.宫颈癌中免疫原性细胞死亡相关的癌相关成纤维细胞簇及预后风险模型
APL Bioeng. 2024 Dec 12;8(4):046114. doi: 10.1063/5.0240772. eCollection 2024 Dec.
4
Research progress in mechanism of anticancer action of shikonin targeting reactive oxygen species.紫草素靶向活性氧的抗癌作用机制研究进展
Front Pharmacol. 2024 Jul 11;15:1416781. doi: 10.3389/fphar.2024.1416781. eCollection 2024.
本文引用的文献
1
Higher-Order Clustering of the Transmembrane Anchor of DR5 Drives Signaling.DR5 跨膜锚的高阶聚类驱动信号转导。
Cell. 2019 Mar 7;176(6):1477-1489.e14. doi: 10.1016/j.cell.2019.02.001. Epub 2019 Feb 28.
2
Structural principles of tumor necrosis factor superfamily signaling.肿瘤坏死因子超家族信号转导的结构原理。
Sci Signal. 2018 Jan 2;11(511):eaao4910. doi: 10.1126/scisignal.aao4910.
3
Principles of antibody-mediated TNF receptor activation.抗体介导的肿瘤坏死因子受体激活原理。
Cell Death Differ. 2015 Nov;22(11):1727-41. doi: 10.1038/cdd.2015.109. Epub 2015 Aug 21.
4
Targeting the extrinsic apoptosis pathway in cancer.靶向癌症中的外源性凋亡途径。
Cytokine Growth Factor Rev. 2008 Jun-Aug;19(3-4):325-31. doi: 10.1016/j.cytogfr.2008.04.001. Epub 2008 May 20.
Zotero 插件